D.A. Davidson & Co’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.61M Buy
34,455
+568
+2% +$157K 0.04% 315
2026
Q1
$10M Buy
33,887
+2,519
+8% +$748K 0.06% 249
2025
Q4
$8.57M Buy
31,368
+274
+0.9% +$74.5K 0.05% 270
2025
Q3
$8.4M Buy
31,094
+69
+0.2% +$18.8K 0.05% 257
2025
Q2
$8.55M Buy
31,025
+131
+0.4% +$35.6K 0.06% 235
2025
Q1
$8.2M Buy
30,894
+587
+2% +$145K 0.07% 227
2024
Q4
$7.04M Buy
30,307
+105
+0.3% +$24.1K 0.06% 241
2024
Q3
$6.66M Buy
30,202
+120
+0.4% +$24.8K 0.06% 253
2024
Q2
$5.91M Buy
30,082
+539
+2% +$111K 0.05% 261
2024
Q1
$6.36M Buy
29,543
+172
+0.6% +$36.1K 0.06% 252
2023
Q4
$6.19M Buy
29,371
+213
+0.7% +$45.4K 0.06% 239
2023
Q3
$5.84M Buy
29,158
+766
+3% +$152K 0.06% 240
2023
Q2
$5.26M Buy
28,392
+547
+2% +$101K 0.06% 257
2023
Q1
$5.33M Buy
27,845
+390
+1% +$70.5K 0.06% 247
2022
Q4
$4.62M Buy
27,455
+361
+1% +$62.7K 0.05% 266
2022
Q3
$4.8M Buy
27,094
+40
+0.1% +$7.91K 0.06% 233
2022
Q2
$5.54M Buy
27,054
+1,143
+4% +$242K 0.07% 222
2022
Q1
$6.16M Buy
25,911
+2
+0% +$470 0.07% 228
2021
Q4
$5.92M Buy
25,909
+968
+4% +$213K 0.06% 241
2021
Q3
$4.82M Buy
24,941
+1,747
+8% +$354K 0.06% 261
2021
Q2
$4.93M Sell
23,194
-364
-2% -$76.9K 0.06% 257
2021
Q1
$4.81M Buy
23,558
+1,246
+6% +$245K 0.06% 237
2020
Q4
$4.06M Sell
22,312
-563
-2% -$95.7K 0.06% 221
2020
Q3
$3.83M Sell
22,875
-2,089
-8% -$352K 0.07% 207
2020
Q2
$4.06M Sell
24,964
-353
-1% -$63.3K 0.08% 181
2020
Q1
$4.38M Buy
25,317
+987
+4% +$196K 0.09% 178
2019
Q4
$4.88M Buy
24,330
+95
+0.4% +$19.5K 0.08% 195
2019
Q3
$5.12M Sell
24,235
-253
-1% -$52.9K 0.09% 175
2019
Q2
$4.75M Sell
24,488
-1,311
-5% -$242K 0.09% 174
2019
Q1
$4.76M Sell
25,799
-3,032
-11% -$536K 0.08% 190
2018
Q4
$5.42M Sell
28,831
-1,076
-4% -$199K 0.11% 157
2018
Q3
$5.09M Buy
29,907
+500
+2% +$84.2K 0.09% 181
2018
Q2
$4.82M Buy
29,407
+2,734
+10% +$447K 0.09% 183
2018
Q1
$4.31M Buy
26,673
+350
+1% +$55.7K 0.09% 188
2017
Q4
$3.85M Sell
26,323
-605
-2% -$86.2K 0.08% 199
2017
Q3
$3.65M Sell
26,928
-2,510
-9% -$317K 0.07% 242
2017
Q2
$3.69M Sell
29,438
-320
-1% -$38.3K 0.08% 193
2017
Q1
$3.54M Sell
29,758
-237
-0.8% -$28.5K 0.09% 196
2016
Q4
$3.46M Buy
29,995
+52
+0.2% +$5.79K 0.08% 244
2016
Q3
$3.13M Buy
29,943
+26,698
+823% +$2.79M 0.08% 244
2016
Q2
$316K Buy
3,245
+120
+4% +$11.3K 0.01% 690
2016
Q1
$300K Sell
3,125
-7,026
-69% -$639K 0.01% 694
2015
Q4
$918K Sell
10,151
-2,087
-17% -$196K 0.03% 416
2015
Q3
$1.13M Buy
12,238
+1,315
+12% +$125K 0.04% 361
2015
Q2
$1.01M Buy
10,923
+7,586
+227% +$708K 0.03% 406
2015
Q1
$315K Buy
3,337
+55
+2% +$5.09K 0.01% 717
2014
Q4
$290K Buy
3,282
+21
+0.6% +$1.78K 0.01% 748
2014
Q3
$259K Sell
3,261
-1
-0% -$75 0.01% 786
2014
Q2
$230K Buy
3,262
+361
+12% +$25.4K 0.01% 846
2014
Q1
$213K Sell
2,901
-94
-3% -$7.09K 0.01% 858
2013
Q4
$232K Buy
2,995
+392
+15% +$30.7K 0.01% 784
2013
Q3
$190K Buy
2,603
+198
+8% +$14.6K 0.01% 713
2013
Q2
$179K Buy
+2,405
New +$158K 0.01% 700

Other funds holding CME

D.A. Davidson & Co's CME Position: Q2 2026 in Review

D.A. Davidson & Co increased its CME Group (CME) stake by 1.7% in Q2 2026, buying an estimated $157K and bringing the position to 34,455 shares worth $7.61M. The position accounts for 0.04% of the portfolio, ranked #315.

D.A. Davidson & Co first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $10M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • D.A. Davidson & Co held 34,455 shares of CME Group worth $7.61M as of Q2 2026.
  • D.A. Davidson & Co bought 568 CME Group shares in Q2 2026, an estimated $157K.
  • CME Group made up 0.04% of D.A. Davidson & Co's portfolio in Q2 2026, its #315 holding.
  • D.A. Davidson & Co first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • D.A. Davidson & Co's CME Group position peaked at $10M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.